Seeking Alpha

Human Genome (HGSI) surges 98% to $14.20 premarket after it reveals it rejected an offer of...

Human Genome (HGSI) surges 98% to $14.20 premarket after it reveals it rejected an offer of $13/share from GSK and that it's carrying out a strategic review.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|